Philip Mudd to Adult
This is a "connection" page, showing publications Philip Mudd has written about Adult.
Connection Strength
0.054
-
Comprehensive Immunologic Evaluation of Bronchoalveolar Lavage Samples from Human Patients with Moderate and Severe Seasonal Influenza and Severe COVID-19. J Immunol. 2021 09 01; 207(5):1229-1238.
Score: 0.016
-
Distinct inflammatory profiles distinguish COVID-19 from influenza with limited contributions from cytokine storm. Sci Adv. 2020 12; 6(50).
Score: 0.015
-
Longitudinal metabolomics of human plasma reveals prognostic markers of COVID-19 disease severity. Cell Rep Med. 2021 08 17; 2(8):100369.
Score: 0.004
-
Expression of Surfactant Protein D Distinguishes Severe Pandemic Influenza A(H1N1) from Coronavirus Disease 2019. J Infect Dis. 2021 07 02; 224(1):21-30.
Score: 0.004
-
Asthma in patients with suspected and diagnosed coronavirus disease 2019. Ann Allergy Asthma Immunol. 2021 05; 126(5):535-541.e2.
Score: 0.004
-
CCR5 inhibition in critical COVID-19 patients decreases inflammatory cytokines, increases CD8 T-cells, and decreases SARS-CoV2 RNA in plasma by day 14. Int J Infect Dis. 2021 Feb; 103:25-32.
Score: 0.004
-
Severe immunosuppression and not a cytokine storm characterizes COVID-19 infections. JCI Insight. 2020 09 03; 5(17).
Score: 0.004
-
Diagnosing COVID-19 in the Emergency Department: A Scoping Review of Clinical Examinations, Laboratory Tests, Imaging Accuracy, and Biases. Acad Emerg Med. 2020 08; 27(8):653-670.
Score: 0.004